Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 350 of 496 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 01/06/16
End: 09/13/16
Due: 09/13/17
Phase: N/A
Priority: Normal
Start: 11/19/20
End: 02/24/23
Due: 02/24/24
Phase: N/A
Priority: Normal
Start: 02/28/06
End: 09/30/12
Due: 09/30/13
Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 03/31/13
Due: 03/31/14
Phase: N/A
Priority: Normal
Start: 12/29/14
End: 03/13/20
Due: 03/13/21
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 08/31/00
End: 09/30/03
Due: 09/30/04
Phase: N/A
Priority: Normal
Start: 06/02/20
End: 02/12/21
Due: 02/12/22
Phase: N/A
Priority: Normal
Start: 12/14/21
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 04/11/16
End: 02/19/20
Due: 02/19/21
Phase: N/A
Priority: Normal
Start: 07/31/07
End: 11/30/09
Due: 11/30/10
Phase: N/A
Priority: Normal
Start: 12/16/24
End: 02/28/27
Due: 02/28/28
Phase: N/A
Priority: Normal
Start: 02/29/04
End: 12/31/06
Due: 12/31/07
Phase: N/A
Priority: Normal
Start: 05/31/07
End: 05/05/08
Due: 05/05/09
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 01/31/15
Due: 01/31/16
Phase: N/A
Priority: Normal
Start: 01/31/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/20/12
End: 03/30/16
Due: 03/30/17
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/14/16
End: 11/12/18
Due: 11/12/19
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 05/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 09/30/13
Due: 09/30/14